Division of Minimally Invasive and Bariatric Surgery, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.
Surg Endosc. 2013 May;27(5):1772-7. doi: 10.1007/s00464-012-2678-5. Epub 2013 Jan 9.
Although the mortality from bariatric surgery is low, perioperative determinants of morbidity and mortality in the bariatric surgery population to date have not been fully defined. This study aimed to evaluate the factors capable of predicting perioperative mortality based on preoperative characteristics with a national patient sample.
From the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database, all the primary bariatric procedures performed between 2007 and 2009 were identified. Using univariate analysis, factors associated with increased perioperative (30-day) mortality were identified. Logistic regression was used to select correlates of 30-day mortality, which were subsequently integrated into a simplified clinical scoring system based on the number of comorbid risk factors.
The study identified 44,408 patients (79 % women, 21 % men) with a mean age of 45 ± 11 years. The cumulative 30-day perioperative mortality rate was 0.14 %. The majority of the procedures performed included laparoscopic gastric bypass (54 %) followed by laparoscopic gastric banding (33 %) and open gastric bypass (7 %). Independent predictors associated with significantly increased mortality included age >45 years [adjusted odds ratio (AOR), 2.45], male gender (AOR = 1.77), a body mass index (BMI) of 50 kg/m(2) or higher (AOR, 2.48), open bariatric procedures (AOR, 2.34), diabetes (AOR, 2.88), functional status of total dependency before surgery (AOR, 27.6), prior coronary intervention (AOR, 2.66), dyspnea at preoperative evaluation (AOR, 4.64), more than 10 % unintentional weight loss in 6 months (AOR, 13.5), and bleeding disorder (AOR, 2.63). Ethnicity, hypertension, alcohol abuse, liver disease, and smoking had no significant association with mortality in this study. Risk stratification based on the number of preoperative comorbid factors showed an exponential increase in mortality as follows: 0-1 comorbidities (0.03 %), 2-3 comorbidities (0.16 %), and 4 comorbidities or more (7.4 %).
This model provides a straightforward, precise, and easily applicable tool for identifying bariatric patients at low, intermediate, and high risk for in-hospital mortality. Notably, baseline functional status before surgery is the single most powerful predictor of perioperative survival and should be incorporated into risk stratification models.
尽管减重手术的死亡率较低,但迄今为止,尚未充分确定肥胖手术人群围手术期发病率和死亡率的决定因素。本研究旨在通过全国患者样本评估基于术前特征预测围手术期死亡率的因素。
从美国外科医师学院国家外科质量改进计划(ACS-NSQIP)数据库中,确定了 2007 年至 2009 年期间进行的所有主要减肥手术。使用单变量分析,确定与围手术期(30 天)死亡率增加相关的因素。使用逻辑回归选择 30 天死亡率的相关因素,随后根据合并症风险因素的数量将其整合到简化的临床评分系统中。
本研究共纳入 44408 名患者(79%为女性,21%为男性),平均年龄为 45±11 岁。累积 30 天围手术期死亡率为 0.14%。大多数手术包括腹腔镜胃旁路手术(54%)、腹腔镜胃带手术(33%)和开腹胃旁路手术(7%)。与死亡率显著增加相关的独立预测因素包括年龄>45 岁[校正优势比(AOR),2.45]、男性(AOR=1.77)、BMI 为 50kg/m2 或更高(AOR,2.48)、开放式减肥手术(AOR,2.34)、糖尿病(AOR,2.88)、术前总依赖状态(AOR,27.6)、冠状动脉介入术前(AOR,2.66)、术前呼吸困难(AOR,4.64)、6 个月内非故意体重减轻超过 10%(AOR,13.5)和出血性疾病(AOR,2.63)。本研究中,种族、高血压、酒精滥用、肝病和吸烟与死亡率无显著相关性。基于术前合并症数量的风险分层显示,死亡率呈指数增长,具体如下:0-1 种合并症(0.03%)、2-3 种合并症(0.16%)和 4 种或更多合并症(7.4%)。
该模型提供了一种简单、精确且易于应用的工具,可用于识别低、中、高住院死亡率风险的肥胖患者。值得注意的是,术前基线功能状态是围手术期生存的唯一最有力预测因素,应纳入风险分层模型。